VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $281,000 | -61.7% | 11,022 | -61.3% | 0.02% | -36.1% |
| Q1 2022 | $733,000 | -25.0% | 28,492 | +22.1% | 0.04% | -23.4% |
| Q4 2021 | $977,000 | +321.1% | 23,339 | +376.3% | 0.05% | +135.0% |
| Q2 2021 | $232,000 | -2.9% | 4,900 | +5.2% | 0.02% | -13.0% |
| Q1 2021 | $239,000 | +16.6% | 4,660 | -39.1% | 0.02% | +9.5% |
| Q4 2020 | $205,000 | -18.3% | 7,655 | +4.9% | 0.02% | -32.3% |
| Q3 2020 | $251,000 | – | 7,297 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |